New User? Sign Up | Sign In

Insider Trading - Aprea Therapeutics Inc. (APRE)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
APRE Insider Trading Transactions for Aprea Therapeutics Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-10-07
Purchase
2019-10-07
7:15 pm
Aprea Therapeutics Inc. APRE Coiante Scott M
CFO
2,500 $15 $37,500 2,500
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:18 pm
Aprea Therapeutics Inc. APRE Attar Eyal C.
SVP Chief Medical Officer
400 $15 $6,000 200
(Indirect
Direct)
View
2019-10-07
Purchase
2019-10-07
7:21 pm
Aprea Therapeutics Inc. APRE Korbel Gregory Alan
VP
500 $15 $7,500 500
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:23 pm
Aprea Therapeutics Inc. APRE HENNEMAN JOHN B III
Director
5,000 $15 $75,000 5,000
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:25 pm
Aprea Therapeutics Inc. APRE Magni Guido
Director
6,500 $15 $97,500 6,500
(Direct)
View
2019-10-07
Purchase
2019-10-07
7:33 pm
Aprea Therapeutics Inc. APRE Christenson Johan
Director
266,667 $15 $4,000,005 2,366,104
(Indirect)
View
2019-10-07
Purchase
2019-10-07
7:39 pm
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect
Direct)
View
2019-10-07
Purchase
2019-10-07
7:40 pm
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect
Direct)
View
2019-10-07
Purchase
2019-10-07
7:53 pm
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
266,667 $15 $4,000,005 2,366,104
(Indirect)
View
2019-10-07
Purchase
2019-10-08
8:13 pm
Aprea Therapeutics Inc. APRE Redmile Group LLC
Green Jeremy
10% Owner
400,000 $15 $6,000,000 2,268,718
(Indirect)
View
2019-10-07
Purchase
2019-10-09
6:23 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
333,333 $15 $4,999,995 333,333
(Indirect)
View
2020-04-13
Sale
2020-04-15
09:18 am
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
210,548 $31.25 $6,579,625 2,234,289
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:31 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
255,000 $35.15 $8,963,250 90,572
(Indirect)
View
2020-05-19
Sale
2020-05-21
9:32 pm
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
255,000 $35.15 $8,963,250 90,572
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:12 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
245,000 $28.75 $7,044,412 80,772
(Indirect)
View
2020-06-11
Sale
2020-06-15
9:13 pm
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
10% Owner
245,000 $28.75 $7,044,412 80,772
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:22 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
DIEKMAN JOHN D
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
PARMAR KUSH
10% Owner
140,000 $33.3 $4,662,000 313,497
(Indirect)
View
2020-06-16
Sale
2020-06-18
7:23 pm
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
10% Owner
120,164 $33.3 $4,001,461 75,965
(Indirect)
View
2020-07-07
Sale
2020-07-07
5:41 pm
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
241,703 $34.55 $8,350,838 1,992,586
(Indirect)
View
2020-10-05
Sale
2020-10-07
9:30 pm
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
ROCKLAGE SCOTT M
Former 10% holder
175,000 $25.3 $4,427,500 138,497
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-10-07
Option Award
2019-10-07
7:15 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Coiante Scott M
CFO
150,824 $15 2,500
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:18 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Attar Eyal C.
SVP Chief Medical Officer
77,630 $15 200
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:19 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Abrahmsen Lars B.
SVP Chief Scientific Officer
77,630 $15 77,630
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:21 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE Korbel Gregory Alan
VP
64,322 $15 500
(Direct)
View
2019-10-07
Option Award
2019-10-07
7:23 pm
N/A
2029-10-02
Aprea Therapeutics Inc. APRE HENNEMAN JOHN B III
Director
18,407 $15 5,000
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
1,913,910 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
79,746 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
492,475 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
20,519 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
1,913,910 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
79,746 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
492,475 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:29 pm
N/A
N/A
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
20,519 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
1,600,559 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
579,647 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
590,445 $0 0
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE KDev Investments AB
Karolinska Development AB
KCIF Co-Investment Fund KB
10% Owner
430,467 $0 0
(Indirect)
View
2019-10-07
Exercise
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Seizinger Bernd R.
Director
263,970 $0.07 0
(Direct)
View
2019-10-07
Exercise
2019-10-07
7:33 pm
N/A
2025-09-04
Aprea Therapeutics Inc. APRE Seizinger Bernd R.
Director
263,970 $0.07 0
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:33 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Christenson Johan
Director
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
1,993,658 $0 333,333
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
512,995 $0 333,333
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
1,993,658 $0 333,333
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:39 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Ventures V LLC
Versant Ventures V GP-GP (Canada) Inc.
Versant Ventures V (Canada) L.P.
Versant Venture Capital V (Canada) LP
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V L.P.
10% Owner
512,995 $0 333,333
(Direct)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,993,658 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
512,995 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,993,658 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:40 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
512,995 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
1,661,382 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-07
7:53 pm
N/A
N/A
Aprea Therapeutics Inc. APRE HealthCap VII L.P.
HealthCap VII GP S.A.
10% Owner
427,496 $0 2,366,104
(Indirect)
View
2019-10-07
Conversion
2019-10-08
8:13 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Redmile Group LLC
Green Jeremy
10% Owner
1,868,718 $0 2,268,718
(Indirect)
View
2019-10-07
Conversion
2019-10-08
8:13 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Redmile Group LLC
Green Jeremy
10% Owner
1,164,674 $0 2,268,718
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
1,913,910 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
79,746 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
492,475 $0 333,333
(Indirect)
View
2019-10-07
Conversion
2019-10-09
6:23 pm
N/A
N/A
Aprea Therapeutics Inc. APRE 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
DIEKMAN JOHN D
Schwab Andrew J.
PARMAR KUSH
10% Owner
20,519 $0 333,333
(Indirect)
View
2020-03-24
Option Award
2020-03-26
5:00 pm
N/A
2030-03-24
Aprea Therapeutics Inc. APRE Coiante Scott M
CFO
55,000 $35.5 55,000
(Direct)
View
2020-03-24
Option Award
2020-03-26
5:01 pm
N/A
2030-03-24
Aprea Therapeutics Inc. APRE Abrahmsen Lars B.
SVP Chief Scientific Officer
31,600 $35.5 31,600
(Direct)
View
2020-03-24
Option Award
2020-03-26
5:01 pm
N/A
2030-03-24
Aprea Therapeutics Inc. APRE Attar Eyal C.
SVP Chief Medical Officer
55,000 $35.5 55,000
(Direct)
View
2020-03-24
Option Award
2020-03-26
5:01 pm
N/A
2030-03-24
Aprea Therapeutics Inc. APRE Korbel Gregory Alan
VP
12,800 $35.5 12,800
(Direct)
View
2020-03-24
Option Award
2020-03-26
5:02 pm
N/A
2030-03-24
Aprea Therapeutics Inc. APRE SCHADE CHRISTIAN S
CEO
127,000 $35.5 127,000
(Direct)
View
2020-05-18
Other
2020-05-20
9:58 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
116,664 $0 0
(Direct)
View
2020-05-18
Other
2020-05-20
9:58 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,750 $0 0
(Indirect)
View
2020-05-18
Other
2020-05-20
9:58 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,750 $0 0
(Indirect)
View
2020-05-18
Other
2020-05-20
9:58 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,734 $0 0
(Indirect)
View
2020-05-18
Other
2020-05-20
9:58 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
1,734 $0 0
(Indirect)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
2,519,323 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
2,210,937 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
66,506 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
73,617 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
168,263 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
773,805 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
23,275 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
25,794 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
58,889 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
16,428 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
16,428 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
1,178 $0 0
(Direct)
View
2020-04-09
Other
2020-05-20
9:59 pm
N/A
N/A
Aprea Therapeutics Inc. APRE Versant V Luxco S.a r.l.
Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
1,178 $0 0
(Direct)
View
2020-06-26
Option Award
2020-06-29
6:04 pm
N/A
2030-06-26
Aprea Therapeutics Inc. APRE Peters Richard
Director
7,000 $38.32 7,000
(Direct)
View
2020-06-26
Option Award
2020-06-29
6:05 pm
N/A
2030-06-26
Aprea Therapeutics Inc. APRE Namouni Fouad
Director
7,000 $38.32 7,000
(Direct)
View
2020-06-30
Option Award
2020-07-01
4:55 pm
N/A
2030-06-30
Aprea Therapeutics Inc. APRE ROCKLAGE SCOTT M
Director
5,600 $38.78 5,600
(Direct)
View
2020-06-30
Option Award
2020-07-01
6:01 pm
N/A
2030-06-30
Aprea Therapeutics Inc. APRE Christenson Johan
Director
5,600 $38.78 5,600
(Direct)
View
2020-06-30
Option Award
2020-07-01
6:03 pm
N/A
2030-06-30
Aprea Therapeutics Inc. APRE Hepple Jonathan
Director
5,600 $38.78 5,600
(Direct)
View
2020-06-30
Option Award
2020-07-01
6:06 pm
N/A
2030-06-30
Aprea Therapeutics Inc. APRE Seizinger Bernd R.
Director
5,600 $38.78 5,600
(Direct)
View
2020-06-30
Option Award
2020-07-01
6:08 pm
N/A
2030-06-30
Aprea Therapeutics Inc. APRE HENNEMAN JOHN B III
Director
5,600 $38.78 5,600
(Direct)
View
2020-09-16
Option Award
2020-09-18
5:05 pm
N/A
2030-09-16
Aprea Therapeutics Inc. APRE Wessels Gregory S.
SVP Chief Commercial Officer
14,700 $28.75 14,700
(Direct)
View
2020-09-28
Option Award
2020-09-29
5:01 pm
N/A
2030-09-28
Aprea Therapeutics Inc. APRE Kelly Michael Aaron
Director
12,000 $22.65 12,000
(Direct)
View
Goto page 0, 1, Next